Drug intelligence / Profile preview

BosPure

Development stage
Unknown
Lead developer
Arjuna Natural
Modality
Small Molecules
Administration
Oral
01

Overview

BosPure is a standardized botanical extract derived from the resin of *Boswellia serrata* (Indian frankincense). It is characterized by a high concentration of Acetyl-11-Keto-Boswellic Acid (AKBA), typically standardized to 10%, and a total boswellic acid content of at least 75%. Unlike conventional Boswellia extracts, BosPure is specifically processed to remove or minimize beta-boswellic acids, which are thought to have pro-inflammatory properties. Its primary mechanism of action involves the inhibition of 5-lipoxygenase (5-LOX), an enzyme responsible for the production of pro-inflammatory leukotrienes. Developed by Arjuna Natural and distributed by Dolcas-Biotech, it is primarily used as a dietary supplement ingredient for supporting joint health, respiratory function, and gastrointestinal comfort.

Brand names
BosPureAKBAMAX
Other names
Boswellia serrata extractIndian frankincense extract
02

Targets

ALOX5 (Arachidonate 5-lipoxygenase)Factor XIaF10 (Factor Xa)VEGFR2 (Vascular endothelial growth factor receptor 2)TOP (DNA topoisomerases)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on BosPure.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BosPure.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call